IL11 and breast carcinoma: Likewise, a 1-h pre-treatment with MG132 attenuated TGF-β-induced IL-11 and PTHrP expression in 1205Lu cells (Figures 3D and 3E, respectively), two known SMAD genes targets implicated in melanoma and breast cancer metastasis to bone [36,43-45].